| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211290 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 35 Pages |
Abstract
Reirradiation both with SBRT and with IMRT appear relatively safe with favorable toxicity compared with historical studies. Outcomes vary by RPA class, which informs clinical trial design. Survival is poor in class III patients, and alternative strategies are needed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
John A. MD, Matthew C. MD, Jimmy J. MD, PhD, Nadeem MD, MS, Neal E. MD, Derek MD, PhD, Sara J. BS, Joshua MD, Musaddiq J. MD, Kristin A. MD, Comron BS, Jonathan J. MD, MBA, FACR, FASTRO, Chandana A. MS, Samuel MD, Drexell H. MD, James A. MD, Min MD, PhD,